October 10, 2020

COVID19 Research Consortium

Closed

About This Events

2019 was a year of dramatic changes in the world with SARS-CoV-2 emerging as the biggest concern. The Pandemic started in Wuhan, China, and has become a public health emergency of global social and economic repercussions. In Sudan, the first reported case was on 13 March 2020 and now cases have reached 13,606 with 836 deaths and a different case fatality rate in comparison to other hardly stricken countries. The Government of Sudan has put in place emergency measures in response to the pandemic while the scientific community struggles to keep pace with understanding a novel and enigmatic infectious agent, its true burden and impact. This meeting, seeks contributions and updates on the COVID 19 Pandemic in Sudan from scientists and practitioners in Sudan, covering various aspects of its biology, epidemiology, clinical manifestation and control.

Overview

150 Participants

22 Programs

19 Speakers

Our Programs

program
10:50 AM - 11:00 AM HALL1

Trend of COVID 19 cases in Sudan:Food for thought

By Prof. Mustafa Khogali

program
11:00 AM - 11:10 AM HALL1

Modelling of COVID19 Outbreak in Sudan

By Prof. Sharief Fadul Babikir

program
11:10 AM - 11:20 AM HALL 1

COVID Testing best practices current situation challenges and future directions

By Dr. Shahinaz Bedri

program
11:20 AM - 11:30 AM HALL 1

Potential role of Gum Arabic (Acacia Senegal) supplementation on immune responses and inflammatory markers among COVID 19 Patients Double Randomized two arms clinical tria

By Dr. Lamis Kaddam ,Dr. Sara Ali

program
11:30 AM - 11:40 AM HALL 1

Preliminary Analysis of Targeted Testing Survey at Khartoum State

By Dr. Shahd Osman

program
11:40 AM - 11:50 AM HALL 1

An open-label, multicenter,randomized, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild/moderate cases of COVID-19 (01- ANTICOV)and ancillary studies

By Prof. Ahmed Mudawi Musa Mohammed

program
11:50 AM - 12:00 PM HALL 1

Identification of host cytokine markers and antibody response to synthetic linear virus B cell epitopes for diagnosis and/ or prognosis of Covid19 infection and genomic sequencing of the virus isolates for molecular tracking of the infection

By Prof.Maowia M.Mukhtar,Dr. Sara I. A.Latif

program
12:00 PM - 12:10 PM HALL 1

Covid 19 receptor variations among different populations

By Mohamed khalid abbas ahmed

program
12:10 PM - 12:20 PM HALL 1

Identification of main protease (Mpro) inhibitors as anticoronaviruses by repurposing FDAapproved drugs using insilico and in vitro methods

By Dr. Abubaker A.M.Abdelbagi

program
12:20 PM - 12:30 PM HALL 1

The Enigma of SARS- cov2 epidemicity in Africa

By Prof.Muntaser Eltayeb Ibrahim

program
12:30 PM - 12:40 PM HALL 1

Coffee and Prayer break

program
12:40 PM - 12:50 PM HALL 1

Questions

By All speakers

program
12:50 PM - 01:00 PM HALL 1

COVID-19 and Neurological disorders (A series of case reports)Khartoum, Sudan 2019

Dr. Khabab Abbasher

program
01:10 PM - 01:20 PM HALL 1

Role of thoracic ultrasound in detecting pulmonary Complications in COVID19

By Dr. Yousif Mohamed Saeed Eltahir

program
01:20 PM - 01:30 PM HALL 1

A Multiple Peptides Vaccine against COVID-19 Designed from the Nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the Immunoinformatics Approach

By PDr. Sahar Obi AbdAlbagi

program
01:30 PM - 01:40 PM HALL 1

COVID19 IN AFRICAN COUNTRIES: is coronavirus spreading too fast?

ByDr. Radi Tuffaha

program
01:40 PM - 01:50 PM HALL 1

Review :- Efficacy and Safety of Immunomodulatory therapy activity of Nigellia sativa seeds oil extract for Corona virus COVID-19 patients

By Mr.Ali Abdalla

program
01:50 PM - 02:00 PM HALL 1

Radiological finding of COVID19 pneumonia

By Dr. Nahla Abdelrahman Owhag Osman

HALL 1					</div>
						<div class=
02:00 PM - 02:10 PM HALL 1

Convalescent plasma a potential therapy in covid-19 patients in low resource setting: Rapid review

By Dr. Abdelrahman Hamza Abdelmoneim

program
02:10 PM - 02:20 PM HALL 1

Immunological stratification of COVID-19 patients from mild to severe, a narrative review

By Dr.Ahmed Seri

program
02:20 PM - 02:30 PM HALL 1

The Association of Lymphocyte count, CRP, D-Dimer, and LDH with Severe Coronavirus Disease 2019 (COVID-19): A Meta-Analysis

By Dr. Almigdad H. M. Ali

program
02:40 PM - 02:50 PM HALL 1

Questions

By All speakers

Our Sponsors

sponsors
sponsors
sponsors

ABSTRACTS

DOWNLOAD NOW